无染料与含染料黏膜下注射液在结直肠LST内镜黏膜下剥离术中的多中心回顾性研究
该多中心回顾性研究纳入526例结直肠侧向发育型肿瘤(LST)行内镜黏膜下剥离术(ESD)患者,比较无染料黏膜下注射液(DFSIs,n=138)与含染料黏膜下注射液(DCSIs,n=388)的有效性与安全性。结果显示两组R0切除、穿孔及术后并发症率相似(均P>0.05),但DFSIs组术中严重出血率显著更低(0.0% vs 3.9%,P=0.015)。亚组分析提示DFSIs在较大或纤维化病变中可能缩短手术时间。
要点
- DFSIs组术中严重出血率显著低于DCSIs组(0.0% vs 3.9%,P=0.015)。
- 两组R0切除、穿孔及术后并发症率无显著差异(均P>0.05)。
- 对于≥3.5 cm、左半结肠或纤维化病变,DFSIs可能缩短手术时间。
核心结论
- 无染料黏膜下注射液用于结直肠LST的ESD安全有效,整体结局与含染料注射液相当。
- 探索性亚组分析提示无染料注射液在复杂病例中可能具有缩短手术时间的优势。
研究设计与样本
- 按所用黏膜下注射液分为无染料组(DFSIs,n=138)和含染料组(DCSIs,n=388)。
主要发现
- 两组基线特征可比。
- DFSIs组术中严重出血率为0.0%,DCSIs组为3.9%(P=0.015)。
- Firth惩罚逻辑回归敏感性分析显示DFSIs与严重出血风险降低相关(OR 0.096,95%CI 0.002-0.960,P=0.026)。
- 亚组分析中,DFSIs在病变≥3.5 cm(P=0.005)、左半结肠病变(P=0.007)、纤维化病变(P=0.040)、使用牵引法(P=0.009)或口袋法(P=0.024)时总手术时间显著缩短。
- 黏膜剥离时间在病变≥3.5 cm(P=0.001)、左半结肠病变(P=0.008)、纤维化病变(P=0.027)及使用牵引法(P=0.036)时也 shorter。
临床怎么用
- 无染料黏膜下注射液可作为结直肠LST的ESD选项,尤其对于高出血风险或复杂病变。
- 对于较大、纤维化或左半结肠病变,可考虑使用无染料注射液以潜在缩短手术时间。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 亚组分析为探索性,结果需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although various submucosal injection solutions are used in endoscopic submucosal dissection (ESD), whether they should routinely contain a staining agent remains debated. This study aimed to compare the efficacy and safety of dye-free submucosal injection solutions (DFSIs) versus dye-containing submucosal injection solution (DCSIs) for colorectal laterally spreading tumors (LSTs). METHODS: This retrospective study included 526 patients with colorectal LSTs who underwent ESD between January 2021 and December 2025. Patients were divided into two groups based on the injection solution used: DFSIs (n = 138) and DCSIs (n = 388). The primary safety endpoint was severe intraoperative bleeding. Primary efficacy endpoints included total procedure time, mucosal dissection time, and submucosal dissection speed. Subgroup analyses were performed according to tumor characteristics and technical factors. RESULTS: Baseline characteristics were comparable between groups. While R0 resection, perforation, and postoperative complication rates were similar (all P > 0.05), the DFSIs group was associated with a significantly lower rate of severe intraoperative bleeding (0.0 vs. 3.9%, P = 0.015). Sensitivity analysis using Firth's penalized logistic regression confirmed a reduced odds of severe bleeding associated with DFSIs (odds ratio 0.096, 95% CI 0.002-0.960, P = 0.026). Subgroup analyses revealed that DFSIs were associated with a statistically significant reduction in total procedure time for lesions ≥ 3.5 cm (P = 0.005), left colon lesions (P = 0.007), fibrotic lesions (P = 0.040), and when traction (P = 0.009) or pocket-creation methods (P = 0.024) were used. Mucosal dissection time was also shorter for lesions ≥ 3.5 cm (P = 0.001), left colon lesions (P = 0.008), fibrotic lesions (P = 0.027), and with traction method (P = 0.036). CONCLUSIONS: DFSIs are safe and effective for colorectal LST ESD. Despite comparable overall outcomes, exploratory subgroup analyses suggested potential advantages of DFSIs in complex cases, including shorter procedure times for larger or fibrotic lesions.
引用
- Zhang Q, Zang F, Xu J, et al. Dye-free versus dye-containing submucosal injection solutions in ESD for colorectal LST: a multi-center retrospective study on efficacy and safety. Surg Endosc. 2026. PMID: 42135496. doi:10.1007/s00464-026-12908-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。